296 related articles for article (PubMed ID: 16183468)
1. Guidelines and challenges for estimating the economic costs and benefits of adolescent substance abuse treatments.
Zavala SK; French MT; Henderson CE; Alberga L; Rowe C; Liddle HA
J Subst Abuse Treat; 2005 Oct; 29(3):191-205. PubMed ID: 16183468
[TBL] [Abstract][Full Text] [Related]
2. Organizational and client determinants of cost in outpatient substance abuse treatment.
Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
[TBL] [Abstract][Full Text] [Related]
3. Economic evaluation of a prerelease substance abuse treatment program for repeat criminal offenders.
French MT; Fang H; Fretz R
J Subst Abuse Treat; 2010 Jan; 38(1):31-41. PubMed ID: 19631489
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
Yeom HS; Shepard DS
J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
[TBL] [Abstract][Full Text] [Related]
5. Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS).
Godfrey C; Stewart D; Gossop M
Addiction; 2004 Jun; 99(6):697-707. PubMed ID: 15139868
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of telemedicine: review of the literature and research guidelines for benefit-cost analysis.
Dávalos ME; French MT; Burdick AE; Simmons SC
Telemed J E Health; 2009 Dec; 15(10):933-48. PubMed ID: 19954346
[TBL] [Abstract][Full Text] [Related]
7. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
Woodward AM; Raskin IE; Blacklow B
Subst Use Misuse; 2008; 43(5):647-79. PubMed ID: 18393082
[TBL] [Abstract][Full Text] [Related]
8. [Assessment of cost-benefit analysis in integration projects on drug addiction].
Ates T; Langer B; Erbas B; Tretter F; Wehner B
Gesundheitswesen; 2005 Feb; 67(2):159-62. PubMed ID: 15747208
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
[TBL] [Abstract][Full Text] [Related]
10. The costs of crime and the benefits of drug abuse treatment: a cost-benefit analysis using TOPS data.
Harwood HJ; Hubbard RL; Collins JJ; Rachal JV
NIDA Res Monogr; 1988; 86():209-35. PubMed ID: 3140032
[No Abstract] [Full Text] [Related]
11. Cost-effectiveness of family-based substance abuse treatment.
Morgan TB; Crane DR
J Marital Fam Ther; 2010 Oct; 36(4):486-98. PubMed ID: 21039660
[TBL] [Abstract][Full Text] [Related]
12. Economic benefits of substance abuse treatment: findings from Cuyahoga County, Ohio.
Koenig L; Siegel JM; Harwood H; Gilani J; Chen YJ; Leahy P; Stephens R
J Subst Abuse Treat; 2005; 28 Suppl 1():S41-50. PubMed ID: 15797638
[TBL] [Abstract][Full Text] [Related]
13. A research agenda for economic evaluation of substance abuse services.
French MT; Drummond M
J Subst Abuse Treat; 2005 Sep; 29(2):125-37. PubMed ID: 16135341
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of relapse prevention for substance users: treatment settings and health care policy.
Yamada T; Chen CC; Yamada T
Adv Health Econ Health Serv Res; 2005; 16():431-50. PubMed ID: 17867251
[TBL] [Abstract][Full Text] [Related]
15. Cost and usage impacts of treatment initiation: a comparison of alcoholism and drug abuse treatments.
Goodman AC; Nishiura E; Humphreys RS
Alcohol Clin Exp Res; 1997 Aug; 21(5):931-8. PubMed ID: 9267547
[TBL] [Abstract][Full Text] [Related]
16. The impact of managed care on publicly funded outpatient adolescent substance abuse treatment: service use and six-month outcomes in Oregon and Washington.
Carlson MJ; Gabriel RM; Deck DD; Laws KE; D'Ambrosio R
Med Care Res Rev; 2005 Jun; 62(3):320-38. PubMed ID: 15894707
[TBL] [Abstract][Full Text] [Related]
17. The quality of highly regarded adolescent substance abuse treatment programs: results of an in-depth national survey.
Brannigan R; Schackman BR; Falco M; Millman RB
Arch Pediatr Adolesc Med; 2004 Sep; 158(9):904-9. PubMed ID: 15351757
[TBL] [Abstract][Full Text] [Related]
18. A critical review of accounting and economic methods for estimating the costs of addiction treatment.
Cartwright WS
J Subst Abuse Treat; 2008 Apr; 34(3):302-10. PubMed ID: 17614244
[TBL] [Abstract][Full Text] [Related]
19. Gender differences in the impact of comprehensive services in substance abuse treatment.
Marsh JC; Cao D; D'Aunno T
J Subst Abuse Treat; 2004 Dec; 27(4):289-300. PubMed ID: 15610830
[TBL] [Abstract][Full Text] [Related]
20. Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?
Ettner SL; Huang D; Evans E; Ash DR; Hardy M; Jourabchi M; Hser YI
Health Serv Res; 2006 Feb; 41(1):192-213. PubMed ID: 16430607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
